Nouveau Life Pharmaceuticals Stock Performance
Nouveau Life holds a performance score of 8 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 0.39, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nouveau Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding Nouveau Life is expected to be smaller as well. Use Nouveau Life Pharmac jensen alpha and semi variance , to analyze future returns on Nouveau Life Pharmac.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nouveau Life Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Nouveau Life showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Nouveau |
Nouveau Life Relative Risk vs. Return Landscape
If you would invest 0.02 in Nouveau Life Pharmaceuticals on August 25, 2024 and sell it today you would lose (0.02) from holding Nouveau Life Pharmaceuticals or give up 100.0% of portfolio value over 90 days. Nouveau Life Pharmaceuticals is currently generating 14.8438% in daily expected returns and assumes 130.53% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Nouveau, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nouveau Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nouveau Life's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nouveau Life Pharmaceuticals, and traders can use it to determine the average amount a Nouveau Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1137
| Best Portfolio | Best Equity | NOUV | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 130.53 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Nouveau Life is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nouveau Life by adding it to a well-diversified portfolio.
Nouveau Life Fundamentals Growth
Nouveau Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nouveau Life, and Nouveau Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nouveau Pink Sheet performance.
| Return On Equity | -2.2 | |||
| Return On Asset | -0.2 | |||
| Current Valuation | 722.68 K | |||
| Price To Earning | (0.01) X | |||
| Price To Book | 22.72 X | |||
| EBITDA | (163.87 K) | |||
| Cash And Equivalents | 1.1 K | |||
| Cash Flow From Operations | (22.91 K) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 1.33 M | |||
| Retained Earnings | (236 K) | |||
| Current Asset | 1 K | |||
| Current Liabilities | 146 K | |||
About Nouveau Life Performance
Evaluating Nouveau Life's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Nouveau Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nouveau Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc. Nouveau Life is traded on OTC Exchange in the United States.Things to note about Nouveau Life Pharmac performance evaluation
Checking the ongoing alerts about Nouveau Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nouveau Life Pharmac help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nouveau Life Pharmac is way too risky over 90 days horizon | |
| Nouveau Life Pharmac has some characteristics of a very speculative penny stock | |
| Nouveau Life Pharmac appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (357.25 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Nouveau Life Pharmaceuticals currently holds about 1.1 K in cash with (22.91 K) of positive cash flow from operations. |
- Analyzing Nouveau Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nouveau Life's stock is overvalued or undervalued compared to its peers.
- Examining Nouveau Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nouveau Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nouveau Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nouveau Life's pink sheet. These opinions can provide insight into Nouveau Life's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Nouveau Pink Sheet Analysis
When running Nouveau Life's price analysis, check to measure Nouveau Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nouveau Life is operating at the current time. Most of Nouveau Life's value examination focuses on studying past and present price action to predict the probability of Nouveau Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nouveau Life's price. Additionally, you may evaluate how the addition of Nouveau Life to your portfolios can decrease your overall portfolio volatility.